Katherine Seley-Radtke
Katherine Seley-Radtke is an American medicinal chemist who specializes in the discovery and design of novel nucleoside or nucleotide based enzyme inhibitors that may be used to treat infections or cancer. She has authored over 90 peer-reviewed publications, is an inventor of five issued US patents, and is a professor in the department of chemistry and biochemistry at the University of Maryland, Baltimore County. Her international impact includes scientific collaborations, policy advising and diplomatic appointments in biosecurity efforts. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Katherine Seley-Radtke', query time: 0.02s
Refine Results
-
1
Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides by Katherine Seley-Radtke
Published 2020-03-01
Article -
2
Synthesis of New 5′-Norcarbocyclic Aza/Deaza Purine Fleximers - Noncompetitive Inhibitors of E.coli Purine Nucleoside Phosphorylase by Anastasia Khandazhinskaya, Ilja Fateev, Irina Konstantinova, Roman Esipov, Konstantin Polyakov, Katherine Seley-Radtke, Sergey Kochetkov, Elena Matyugina
Published 2022-05-01
Article -
3
-
4
New Flexible Analogues of 8-Aza-7-deazapurine Nucleosides as Potential Antibacterial Agents by Anastasia Khandazhinskaya, Barbara Eletskaya, Anton Mironov, Irina Konstantinova, Olga Efremenkova, Sofya Andreevskaya, Tatiana Smirnova, Larisa Chernousova, Evgenia Kondrashova, Alexander Chizhov, Katherine Seley-Radtke, Sergey Kochetkov, Elena Matyugina
Published 2023-10-01
Article